Javed Butler1, Muhammad Shahzeb Khan2, Claudio Mori3, Gerasimos S Filippatos4,5, Piotr Ponikowski6, Josep Comin-Colet7, Bernard Roubert3, John A Spertus8, Stefan D Anker9. 1. Department of Medicine, University of Mississippi, Jackson, MO, USA. 2. Department of Medicine, Cook County Hospital, Chicago, IL, USA. 3. Vifor Pharma Ltd., Glattbrugg, Switzerland. 4. Medical School, University of Cyprus, Nicosia, Cyprus. 5. National and Kapodistrian University of Athens, Athens University Hospital Attikon, Athens, Greece. 6. Wroclaw Medical University, Wroclaw, Poland. 7. Department of Cardiology, Bellvitge University Hospital and IDIBELL, University of Barcelona, Hospitalet de Llobregat, Barcelona, Spain. 8. Department of Cardiology, University of Missouri-Kansas City, Saint Luke's Mid America Heart Institute, Kansas City, MO, USA. 9. Department of Cardiology (CVK); and Berlin Institute of Health Center for Regenerative Therapies (BCRT), German Center for Cardiovascular Research (DZHK) partner site Berlin; Charité Universitätsmedizin Berlin, Berlin, Germany.
Abstract
AIMS: While the associations of health-related quality of life scores in heart failure (HF) [e.g. the Kansas City Cardiomyopathy Questionnaire (KCCQ)] with clinical outcomes are well established, their interpretation in the context of what magnitudes of change are clinically important to patients is less clear. The main objective of this study was to correlate the changes in the KCCQ and Patient Global Assessment (PGA) in patients with HF with reduced ejection fraction (HFrEF) to determine minimal clinically important difference (MCID). METHODS AND RESULTS: We analysed data from 459 patients of the FAIR-HF trial. Both KCCQ and PGA were assessed at 4 and 24 weeks after enrolment. An anchor-based approach was used to calculate MCID at week 4 and 24. PGA was chosen as the clinical anchor against which changes in the KCCQ scores were calibrated. For each category of change in PGA, the corresponding differences were calculated by the mean scores of various domains of KCCQ along with 95% confidence intervals (CIs). There was fair correlation between PGA and changes in overall summary scores (OSS) (r = 0.31; P < 0.001), clinical summary scores (CSS) (r = 0.36; P < 0.001) and physical limitation scores (PLS) (r = 0.31; P < 0.001) from baseline to week 4. KCCQ OSS, CSS and PLS MCID for 'little improvement' at week 4 were 3.6 (1.0-6.2), 4.5 (1.8-7.2) and 4.7 (1.4-8.0) points, respectively. OSS, CSS and PLS MCID for 'little improvement' at week 24 were 4.3 (0.2-8.4), 4.5 (0.5-8.5) and 4.0 (-0.9-9.0) points, respectively. CONCLUSION: The MCID threshold for KCCQ score was generally consistent and numerically lower than the threshold of 5-point change considered for clinical outcome prognosis and were stable between 4 and 24 weeks. This suggests that even changes smaller than the traditional 5-point improvements in KCCQ may be clinically meaningful. Also, these results can aid in the clinical interpretation of patient-reported outcomes, and better endpoint selection in future studies.
AIMS: While the associations of health-related quality of life scores in heart failure (HF) [e.g. the Kansas City Cardiomyopathy Questionnaire (KCCQ)] with clinical outcomes are well established, their interpretation in the context of what magnitudes of change are clinically important to patients is less clear. The main objective of this study was to correlate the changes in the KCCQ and Patient Global Assessment (PGA) in patients with HF with reduced ejection fraction (HFrEF) to determine minimal clinically important difference (MCID). METHODS AND RESULTS: We analysed data from 459 patients of the FAIR-HF trial. Both KCCQ and PGA were assessed at 4 and 24 weeks after enrolment. An anchor-based approach was used to calculate MCID at week 4 and 24. PGA was chosen as the clinical anchor against which changes in the KCCQ scores were calibrated. For each category of change in PGA, the corresponding differences were calculated by the mean scores of various domains of KCCQ along with 95% confidence intervals (CIs). There was fair correlation between PGA and changes in overall summary scores (OSS) (r = 0.31; P < 0.001), clinical summary scores (CSS) (r = 0.36; P < 0.001) and physical limitation scores (PLS) (r = 0.31; P < 0.001) from baseline to week 4. KCCQ OSS, CSS and PLS MCID for 'little improvement' at week 4 were 3.6 (1.0-6.2), 4.5 (1.8-7.2) and 4.7 (1.4-8.0) points, respectively. OSS, CSS and PLS MCID for 'little improvement' at week 24 were 4.3 (0.2-8.4), 4.5 (0.5-8.5) and 4.0 (-0.9-9.0) points, respectively. CONCLUSION: The MCID threshold for KCCQ score was generally consistent and numerically lower than the threshold of 5-point change considered for clinical outcome prognosis and were stable between 4 and 24 weeks. This suggests that even changes smaller than the traditional 5-point improvements in KCCQ may be clinically meaningful. Also, these results can aid in the clinical interpretation of patient-reported outcomes, and better endpoint selection in future studies.
Keywords:
Heart failure; Kansas City Cardiomyopathy Questionnaire; Minimal clinically important difference; Patient Global Assessment; Patient-reported outcomes; Quality of life
Authors: Marie A Bakitas; J Nicholas Dionne-Odom; Deborah B Ejem; Rachel Wells; Andres Azuero; Macy L Stockdill; Konda Keebler; Elizabeth Sockwell; Sheri Tims; Sally Engler; Karen Steinhauser; Elizabeth Kvale; Raegan W Durant; Rodney O Tucker; Kathryn L Burgio; Jose Tallaj; Keith M Swetz; Salpy V Pamboukian Journal: JAMA Intern Med Date: 2020-09-01 Impact factor: 21.873
Authors: Macy L Stockdill; J Nicholas Dionne-Odom; Rachel Wells; Deborah Ejem; Andres Azuero; Konda Keebler; Elizabeth Sockwell; Sheri Tims; Kathryn L Burgio; Sally Engler; Raegan Durant; Salpy V Pamboukian; Jose Tallaj; Keith M Swetz; Elizabeth Kvale; Rodney Tucker; Marie Bakitas Journal: J Palliat Care Date: 2020-12-01 Impact factor: 1.980
Authors: Francesco Giallauria; Gianluigi Cuomo; Alessandro Parlato; Nirav Y Raval; Jürgen Kuschyk; Andrew Js Stewart Coats Journal: ESC Heart Fail Date: 2020-07-23
Authors: Javed Butler; Stefan D Anker; Gerasimos Filippatos; Muhammad Shahzeb Khan; João Pedro Ferreira; Stuart J Pocock; Nadia Giannetti; James L Januzzi; Ileana L Piña; Carolyn S P Lam; Piotr Ponikowski; Naveed Sattar; Subodh Verma; Martina Brueckmann; Waheed Jamal; Ola Vedin; Barbara Peil; Cordula Zeller; Faiez Zannad; Milton Packer Journal: Eur Heart J Date: 2021-03-31 Impact factor: 29.983
Authors: John A Spertus; Mary C Birmingham; Javed Butler; Ildiko Lingvay; David E Lanfear; Antonio Abbate; Mikhail L Kosiborod; Christina Fawcett; Paul Burton; C V Damaraju; James L Januzzi; John Whang Journal: Circ Heart Fail Date: 2021-03-16 Impact factor: 8.790
Authors: Nicolette Stogios; Gabriel Fezza; Julia V Wong; Heather J Ross; Michael E Farkouh; Robert P Nolan Journal: Eur J Heart Fail Date: 2021-03-08 Impact factor: 15.534